Attach9_Specialty Clinical Services List.docx
DOCX document 25 KB Posted
- Attached to
- Draft RFP Elements for Comment - TRICARE Pharmacy Program, Fourth Generation (TPharm4) - AMENDMENT 1
- Solicitation number
- HT9402-13-R-0001
- Issued by
-
Defense Health Agency
About this file
Attach9_Specialty Clinical Services List
View the file
Other files
| File | Type | Posted |
|---|---|---|
| DRAFT_RFP_Section_X_Composite_-_Guarantee_(Oct_4 _2012).docx | DOCX document | |
| Attach5_SRP Sites.doc | DOC document | |
| Attach4_MTF Sites.xls | XLS spreadsheet | |
| Attach6_Required Mailings.doc | DOC document | |
| DRAFT RFP Section B | — | |
| DRAFT RFP Section C | — | |
| Attach2_Deployed Prescription Volume.xls | XLS spreadsheet | |
| Attach7_Bulk Chemicals Used for Compounding Final Report 07 23 12.xlsx | XLSX spreadsheet | |
| Attach8__ Enhanced IA Standards Checklist IAW H4.pdf | ||
| Attach1_Utilization Data.xls | XLS spreadsheet | |
| DRAFT RFP Section L | — | |
| DRAFT RFP Section F | — | |
| DRAFT RFP Section H | — | |
| Attach3_MTF Workload.xls | XLS spreadsheet |
Show all 14
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
MEDICATIONS REQUIRING SPECIALTY CLINICAL SERVICES*
ADRENOCORTICOTROPHIC HORMONE
ACTH
ACTHAR H.P.
AGENTS TO TREAT MULTIPLE SCLEROSIS
AVONEX
BETASERON
COPAXONE
EXTAVIA
GILENYA
REBIF
AMPYRA
ANTINEOPLASTIC AGENTS
ALKERAN
CYCLOPHOSPHAMIDE
METHOTREXATE
VIDAZA
ERIVEDGE
HEXALEN
LEUKERAN
TRETINOIN CAPSULE
TABLOID
XELODA
TEMODAR
JAKAFI
ZYTIGA
THALIDOMID
ZOLINZA
AFINITOR
HYCAMTIN
CAPRELSA
GLEEVEC
NEXAVAR
SPRYCEL
SUTENT
INLYTA
TARCEVA
IRESSA
TASIGNA
TYKERB
VANDETANIB
HYDROXYUREA
VOTRIENT
MATULANE
LYSODREN
MERCAPTOPURINE
XALKORI
ZELBORAF
ELIGARD
LEUPROLIDE ACETATE
LUPRON
NILANDRON
CASODEX
FLUTAMIDE
ZOLADEX
FIRMAGON
THERACYS
ETOPOSIDE
REVLIMID
SYLATRON
8-MOP
AGENTS FOR CYSTIC FIBROSIS
TOBI
CAYSTON
PULMOZYME
HYPERTONIC SALINE FOR INHALATION
AMYOTROPHIC LATERAL SCLEROSIS AGENT
RILUTEK
DISEASE MODIFYING ANTI-RHEUMATIC DRUGS
METHOTREXATE
RHEUMATREX
KINARET
SIMPONI
ORENCIA
ENBREL
HUMIRA
CIMZIA
SULFASALAZINE
AZATHIOPRINE
LEFLUNOMIDE
ANTIDIURETIC AND VASOPRESSOR HORMONE
DDAVP
DESMOPRESSIN ACETATE
MINIRIN
ANTIHEMOPHILIC FACTOR
BIOCLATE
FEIBA NF
FEIBA VH IMMUNO
GENARC
HELIXATE FS
HEMOFIL M
HUMATE-P
KOATE-DVI
KOATE-HP
KOGENATE FS
MONOCLATE-P
RECOMBINATE
XYNTHA
ALPHANINE HEAT-TREAT/SOLV S
ALPHANINE SD
ALPHANINE SD HEAT TREAT/SOL
BEBULIN
BEBULIN VH IMMUNO
BENEFIX
MONONINE
ANTI-NARCOLEPSY & ANTI-CATAPLEXY
XYREM
ANTIPARKINSONISM DRUGS
APOKYN
ANTIPSORIATIC AGENTS
AMEVIVE
ANTISERA
BAYHEP B
H-BIG
HEP-B-GAMMAGEE
HYPERHEP
NABI-HB
RHOPHYLAC
VARICELLA-ZOSTER IMM GLOBUL
WINRHO SD
WINRHO SDF
ANTIVIRALS, HIV-SPECIFIC
APTIVUS
PREZISTA
TRUVADA
COMBIVIR
EPZICOM
LAMIVUDINE-ZIDOVUDINE
TRIZIVIR
SELZENTRY
FUZEON
EDURANT
INTELENCE
NEVIRAPINE
RESCRIPTOR
SUSTIVA
VIRAMUNE
VIRAMUNE XR
ABACAVIR
DIDANOSINE
EMTRIVA
EPIVIR
LAMIVUDINE
RETROVIR
STAVUDINE
VIDEX EC
ZERIT
ZIAGEN
ZIDOVUDINE
VIREAD
CRIXIVAN
INVIRASE
LEXIVA
NORVIR
REYATAZ
VIRACEPT
KALETRA
ISENTRESS
ATRIPLA
COMPLERA
C1 ESTERASE INHIBITOR
BERINERT
CHEMOTHERAPY RESCUE/ANTIDOTE AGENT
LEUCOVORIN CALCIUM
MESNEX
CXCR4 CHEMOKINE RECEPTOR ANTAGONIS
MOZOBIL
DRUGS TO TREAT HEREDITARY TYROSINEMIA
ORFADIN
DRUGS TO TX GAUCHER DISEASE
ZAVESCA
BLOOD CELL STIMULATING AGENTS
ARANESP
EPOGEN
PROCRIT
MOZOBIL
NPLATE
PROMACTA
LEUKINE
NEULASTA
NEUMEGA
GASTRIC ENZYME
SUCRAID
GROWTH HORMONE
GENOTROPIN
HUMATROPE
GROWTH HORMONE RECEPTOR ANTAGONIST
SOMAVERT
GROWTH HORMONE RELEASING HORMONE (GHRH) & ANALOG
EGRIFTA
HEPATITIS B TREATMENT AGENT
EPIVIR HBV
HEPATITIS C TREATMENT AGENT
COPEGUS
INFERGEN
PEGASYS
PEGINTRON
PEGINTRON REDIPEN
REBETOL
RIBAPAK
RIBASPHERE
RIBATAB
RIBAVIRIN
INCIVEK
VICTRELIS
IMMUNOMODULATOR
ACTIMMUNE
INTRON A
IMMUNOSUPPRESSIVE
CELLCEPT
CYCLOSPORINE
CYCLOSPORINE MODIFIED
GENGRAF
HECORIA
MYCOPHENOLATE MOFETIL
MYFORTIC
NEORAL
PROGRAF
RAPAMUNE
SANDIMMUNE
SANGCYA
TACROLIMUS
ZORTRESS
INSULIN-LIKE GROWTH FACTOR-1 (IGF-1) HORMONE
INCRELEX
KIDNEY STONE AGENT
CYSTAGON
NON-ANTINEOPLASTIC PITUITARY SUPPRESSANTS
LUPRON DEPOT
LUPRON DEPOT-3 MONTH
SUPPRELIN LA
VANTAS
CETROTIDE
LUPRON DEPOT-PEDS
CHELATING AGENTS
EXJADE
FERRIPROX
MONOCLONAL ANTIBODIES TO IMMUNOGLOBULIN E (IGE
XOLAIR
MONOCLONAL ANTIBODY-HUMAN INTERLEUKIN 12/23 INHI
STELARA
MOVEMENT DISORDERS (DRUG THERAPY
XENAZINE
AGENTS TO TREAT PHENYLKETONURIA
KUVAN
PROGESTATIONAL AGENT
GESTEROL-50
PROGESTERONE
PROGESTERONE 50 IN OIL
PROGESTERONE IN OIL
PROGESTERONE-50 IN OIL
ROGEST 50
AGENTS TO TREAT PULMONARY HYPERTENSION
ADCIRCA
REVATIO
LETAIRIS
TRACLEER
TYVASO
VENTAVIS
SOMATOSTATIC AGENT
OCTREOTIDE ACETATE
SANDOSTATIN
SANDOSTATIN LAR
SOMATULINE DEPOT
*This list provides therapy classes with examples of medications that require specialty clinical services. The therapy classes and medications listed are subjected to change.
DRAFT 31 July 2012
File details come from the government source that posted it. Updated .